Pharmasset, Inc. Overview

State:New Jersey
Country:United States
Industry:Biotechnology and Drugs
Description:
Pharmasset, Inc. (Pharmasset) is a clinical-stage pharmaceutical company engaged in discovering, developing, and commercializing drugs to treat viral infections. Its primary focus is on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection and secondarily, on the development of Racivir for the treatment of human immunodeficiency virus (HIV) infection. Nucleoside/tide analogs are a class of compounds, which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. As of September 30, 2009, the Company had three clinical-stage product candidates, two of which it is developing itself and one of which the Company is developing with a strategic partner.... (More)

Get Trial Access to OneSource

Company profiles, executive contacts, industry research, and news for sales, marketing and research professionals.

Disclaimer: While the OneSource Subscription Service maintains the freshest, most accurate data possible, this free site is refreshed on a periodic basis and may occasionally contain information that is not current. If you would like to alert us to a change, please email us, and we will take steps to make sure your update is included as soon as possible

Pharmasset, Inc. Overview

Get Trial Access to OneSource

Business Information

Executive Profiles

Company Lists